ReviewBurns & trauma2016
The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring.
Review in Burns & trauma, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 31 citations in OpenAlex.
- Microneedles as an Emerging Platform for Transdermal Delivery of Phytochemicals.Molecular pharmaceutics · 2024Review
- How Thymoquinone fromCurrent issues in molecular biology · 2023Review
- From In Silico Simulation between TGF-Life (Basel, Switzerland) · 2023Article
- Wound Healing Properties of Natural Products: Mechanisms of Action.Molecules (Basel, Switzerland) · 2023Review
- Kampo herbal ointments for skin wound healing.Frontiers in pharmacology · 2023Review
- Article
- Marine Polysaccharides for Wound Dressings Application: An Overview.Pharmaceutics · 2021Review
- Resveratrol inhibits hypertrophic scars formation by activating autophagy via the miR-4654/Rheb axis.Molecular medicine reports · 2020Article
- Resveratrol-loaded peptide-hydrogels inhibit scar formation in wound healing through suppressing inflammation.Regenerative biomaterials · 2020Article
- Effectiveness and Tolerability of a Patch Containing Onion Extract and Allantoin for Cesarean Section Scars.Frontiers in pharmacology · 2020Article
- Novel pharmacotherapy for burn wounds: what are the advancements.Expert opinion on pharmacotherapy · 2019Review
- Bioprinting of skin constructs for wound healing.Burns & trauma · 2018Review
- "Scarless world or scar-less world": expedition on new perspectives on management of post-burn hypertrophic scar.Burns & trauma · 2016Article
- Evidence of Potential Natural Products for the Management of Hypertrophic Scars.Journal of evidence-based integrative medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Though survival rate following severe thermal injuries has improved, the incidence and treatment of scarring have not improved at the same speed. This review discusses the formation of scars and in particular the formation of hypertrophic scars. Further, though there is as yet no gold standard treatment for the prevention or treatment of scarring, a brief overview is included. A number of natural therapeutics have shown beneficial effects both in vivo and in vitro with the potential of becoming clinical therapeutics in the future. These natural therapeutics include both plant-based products such as resveratrol, quercetin and epigallocatechin gallate as examples and includes the non-plant-based therapeutic honey. The review also includes potential mechanism of action for the therapeutics, any recorded adverse events and current administration of the therapeutics used. This review discusses a number of potential 'treatments' that may reduce or even prevent scarring particularly hypertrophic scarring, which is associated with thermal injuries without compromising wound repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.